Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SingVax-01: High-Dose vs Standard-Dose Seasonal Influenza Vaccines in Older Adults in Singapore
NCT07883421Phase 4Not yet recruiting
- Sponsor
- Tan Tock Seng Hospital
- Start
- Nov 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of influenza vaccine in influenza (2 arms), sponsored by Tan Tock Seng Hospital. Primary endpoint: Geometric Mean Titre ratio (HD-IIV/SD-IIV) for A/H3N2 strain at Day 14. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07883421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07883421.